Cargando…
Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study
INTRODUCTION: Children with the single-gene disorder neurofibromatosis type 1 (NF1) appear to be at an increased risk for autism spectrum disorder (ASD) and exhibit a unique social-cognitive phenotype compared with children with idiopathic ASD. A complete framework is required to better understand a...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773330/ https://www.ncbi.nlm.nih.gov/pubmed/31558455 http://dx.doi.org/10.1136/bmjopen-2019-030601 |
_version_ | 1783455880418689024 |
---|---|
author | Haebich, Kristina M Pride, Natalie A Walsh, Karin S Chisholm, Anita Rouel, Melissa Maier, Alice Anderson, Vicki Barton, Belinda Silk, Tim Korgaonkar, Mayuresh Seal, Marc Lami, Francesca Lorenzo, Jennifer Williams, Katrina Dabscheck, Gabriel Rae, Caroline D Kean, Michael North, Kathryn N Payne, Jonathan M |
author_facet | Haebich, Kristina M Pride, Natalie A Walsh, Karin S Chisholm, Anita Rouel, Melissa Maier, Alice Anderson, Vicki Barton, Belinda Silk, Tim Korgaonkar, Mayuresh Seal, Marc Lami, Francesca Lorenzo, Jennifer Williams, Katrina Dabscheck, Gabriel Rae, Caroline D Kean, Michael North, Kathryn N Payne, Jonathan M |
author_sort | Haebich, Kristina M |
collection | PubMed |
description | INTRODUCTION: Children with the single-gene disorder neurofibromatosis type 1 (NF1) appear to be at an increased risk for autism spectrum disorder (ASD) and exhibit a unique social-cognitive phenotype compared with children with idiopathic ASD. A complete framework is required to better understand autism in NF1, from neurobiological levels through to behavioural and functional outcomes. The primary aims of this study are to establish the frequency of ASD in children with NF1, examine the social cognitive phenotype, investigate the neuropsychological processes contributing to ASD symptoms and poor social functioning in children with NF1, and to investigate novel structural and functional neurobiological markers of ASD and social dysfunction in NF1. The secondary aim of this study is to compare the neuropsychological and neurobiological features of ASD in children with NF1 to a matched group of patients with idiopathic ASD. METHODS AND ANALYSIS: This is an international, multisite, prospective, cross-sectional cohort study of children with NF1, idiopathic ASD and typically developing (TD) controls. Participants will be 200 children with NF1 (3–15 years of age), 70 TD participants (3–15 years) and 35 children with idiopathic ASD (7–15 years). Idiopathic ASD and NF1 cases will be matched on age, sex and intelligence. All participants will complete cognitive testing and parents will rate their child’s behaviour on standardised questionnaires. Neuroimaging will be completed by a subset of participants aged 7 years and older. Children with NF1 that screen at risk for ASD on the parent-rated Social Responsiveness Scale 2nd Edition will be invited back to complete the Autism Diagnostic Observation Scale 2nd Edition and Autism Diagnostic Interview-Revised to determine whether they fulfil ASD diagnostic criteria. ETHICS AND DISSEMINATION: This study has hospital ethics approval and the results will be disseminated through peer-reviewed publications and international conferences. |
format | Online Article Text |
id | pubmed-6773330 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-67733302019-10-21 Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study Haebich, Kristina M Pride, Natalie A Walsh, Karin S Chisholm, Anita Rouel, Melissa Maier, Alice Anderson, Vicki Barton, Belinda Silk, Tim Korgaonkar, Mayuresh Seal, Marc Lami, Francesca Lorenzo, Jennifer Williams, Katrina Dabscheck, Gabriel Rae, Caroline D Kean, Michael North, Kathryn N Payne, Jonathan M BMJ Open Paediatrics INTRODUCTION: Children with the single-gene disorder neurofibromatosis type 1 (NF1) appear to be at an increased risk for autism spectrum disorder (ASD) and exhibit a unique social-cognitive phenotype compared with children with idiopathic ASD. A complete framework is required to better understand autism in NF1, from neurobiological levels through to behavioural and functional outcomes. The primary aims of this study are to establish the frequency of ASD in children with NF1, examine the social cognitive phenotype, investigate the neuropsychological processes contributing to ASD symptoms and poor social functioning in children with NF1, and to investigate novel structural and functional neurobiological markers of ASD and social dysfunction in NF1. The secondary aim of this study is to compare the neuropsychological and neurobiological features of ASD in children with NF1 to a matched group of patients with idiopathic ASD. METHODS AND ANALYSIS: This is an international, multisite, prospective, cross-sectional cohort study of children with NF1, idiopathic ASD and typically developing (TD) controls. Participants will be 200 children with NF1 (3–15 years of age), 70 TD participants (3–15 years) and 35 children with idiopathic ASD (7–15 years). Idiopathic ASD and NF1 cases will be matched on age, sex and intelligence. All participants will complete cognitive testing and parents will rate their child’s behaviour on standardised questionnaires. Neuroimaging will be completed by a subset of participants aged 7 years and older. Children with NF1 that screen at risk for ASD on the parent-rated Social Responsiveness Scale 2nd Edition will be invited back to complete the Autism Diagnostic Observation Scale 2nd Edition and Autism Diagnostic Interview-Revised to determine whether they fulfil ASD diagnostic criteria. ETHICS AND DISSEMINATION: This study has hospital ethics approval and the results will be disseminated through peer-reviewed publications and international conferences. BMJ Publishing Group 2019-09-26 /pmc/articles/PMC6773330/ /pubmed/31558455 http://dx.doi.org/10.1136/bmjopen-2019-030601 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Paediatrics Haebich, Kristina M Pride, Natalie A Walsh, Karin S Chisholm, Anita Rouel, Melissa Maier, Alice Anderson, Vicki Barton, Belinda Silk, Tim Korgaonkar, Mayuresh Seal, Marc Lami, Francesca Lorenzo, Jennifer Williams, Katrina Dabscheck, Gabriel Rae, Caroline D Kean, Michael North, Kathryn N Payne, Jonathan M Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study |
title | Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study |
title_full | Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study |
title_fullStr | Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study |
title_full_unstemmed | Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study |
title_short | Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study |
title_sort | understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study |
topic | Paediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773330/ https://www.ncbi.nlm.nih.gov/pubmed/31558455 http://dx.doi.org/10.1136/bmjopen-2019-030601 |
work_keys_str_mv | AT haebichkristinam understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy AT pridenataliea understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy AT walshkarins understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy AT chisholmanita understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy AT rouelmelissa understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy AT maieralice understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy AT andersonvicki understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy AT bartonbelinda understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy AT silktim understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy AT korgaonkarmayuresh understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy AT sealmarc understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy AT lamifrancesca understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy AT lorenzojennifer understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy AT williamskatrina understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy AT dabscheckgabriel understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy AT raecarolined understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy AT keanmichael understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy AT northkathrynn understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy AT paynejonathanm understandingautismspectrumdisorderandsocialfunctioninginchildrenwithneurofibromatosistype1protocolforacrosssectionalmultimodalstudy |